(GENK) GEN Restaurant Common - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US36870C1045

GENK: Korean, BBQ, Meats, Poultry, Seafood

GEN Restaurant Group, Inc. Class A Common Stock (NASDAQ:GENK) operates a chain of restaurants specializing in Korean-inspired barbecue, with locations across California, Arizona, Hawaii, Nevada, Texas, New York, and Florida. The company focuses on offering premium meats, poultry, and seafood, leveraging traditional Korean barbecue methods. Founded in 2011 and headquartered in Cerritos, California, GEN Restaurant Group has established itself as a key player in the casual dining sector, emphasizing high-quality ingredients and authentic culinary experiences. Web URL: https://www.genkoreanbbq.com

Ticker Symbol: GENK
Exchange: NASDAQ
Type: common stock
Country Origin: United States
GICS Sub Industry: Restaurants

Based on and , GENK is currently trading at $5.67 with a 20-day average volume of 67,702 shares. The stocks short-term technical outlook is mixed, with the 20-day SMA at $5.72 and the 50-day SMA at $6.61, indicating recent weakness. The 200-day SMA of $8.39 reflects longer-term downward momentum. The ATR of 0.37 suggests moderate volatility. On the fundamental side, GENK has a market cap of $190.24M, with a trailing P/E of 2.79 and a forward P/E of 144.93, signaling potential valuation discrepancies. The P/B ratio of 2.37 and P/S ratio of 0.96 indicate attractive valuations relative to book value and sales. However, the RoE of 2.47% highlights margin pressures and operational efficiency challenges.

Over the next three months, GENK is expected to face headwinds from its declining 200-day SMA and elevated forward P/E. However, the stocks proximity to its 20-day SMA support level and low ATR may limit downside risks. Fundamental analysis suggests the companys attractive P/B and P/S ratios could attract value investors, but the high forward P/E and low RoE may deter growth-oriented buyers. Forecast: Sideways trading with potential for modest upside if the company demonstrates improved earnings visibility.

Additional Sources for GENK Stock

GENK Stock Overview

Market Cap in USD 148m
Sector Consumer Cyclical
Industry Restaurants
GiC Sub-Industry Restaurants
IPO / Inception 2023-06-28

GENK Stock Ratings

Growth 5y -54.2%
Fundamental -17.9%
Dividend 0.0%
Rel. Strength -61.3
Analysts 4.67/5
Fair Price Momentum 3.03 USD
Fair Price DCF -

GENK Dividends

No Dividends Paid

GENK Growth Ratios

Growth Correlation 3m -70.9%
Growth Correlation 12m -87.4%
Growth Correlation 5y -64%
CAGR 5y -51.68%
CAGR/Max DD 5y -0.65
Sharpe Ratio 12m -1.79
Alpha -53.70
Beta 1.152
Volatility 61.38%
Current Volume 55.9k
Average Volume 20d 56.7k
What is the price of GENK stocks?
As of April 10, 2025, the stock is trading at USD 4.20 with a total of 55,880 shares traded.
Over the past week, the price has changed by -23.22%, over one month by -25.93%, over three months by -44.52% and over the past year by -61.85%.
Is GEN Restaurant Common a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, GEN Restaurant Common is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.88 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GENK as of April 2025 is 3.03. This means that GENK is currently overvalued and has a potential downside of -27.86%.
Is GENK a buy, sell or hold?
GEN Restaurant Common has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy GENK.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for GENK stock price target?
According to ValueRays Forecast Model, GENK GEN Restaurant Common will be worth about 3.4 in April 2026. The stock is currently trading at 4.20. This means that the stock has a potential downside of -19.76%.
Issuer Forecast Upside
Wallstreet Target Price 11.3 169.8%
Analysts Target Price 13.2 213.6%
ValueRay Target Price 3.4 -19.8%